Distinguished Professor of Medicine, Co-Director, Hematology Malignancy Program; Director, Center for Novel Therapies; Evelyn and Edwin Tasch Chair in Cancer Research
UC San Diego, Moores Cancer Center
Thomas Kipps, MD, PhD, is a Distinguished Professor of Medicine, Director of the Center for Novel Therapeutics, and Co-Director of the Hematologic Malignancies Program at the University of California, San Diego, Moores Cancer Center. He received his Ph.D. in Immunology and M.D. from Harvard University and had his residency and fellowship training in Internal Medicine, Hematology, and Genetics at Stanford University.
Dr. Kipps holds the Evelyn and Edwin Tasch Chair in Cancer Research, is a two-time awardee of a Specialized Center of Research (SCOR) in Leukemia grant from the Leukemia and Lymphoma Society, a two-time awardee of the NIH MERIT Award, and principal investigator of the CLL Research Consortium (CRC), which directed inter-institutional research among the leading investigators in CLL from across the country and abroad. He is also an awardee of the Rai/Binet medal for outstanding contributions to the field of leukemia research, and the Michael J. Keating Outstanding Achievement Award from the Society of Hematologic Oncology for advancing knowledge of and treatments for blood cancers. He is Chair of the international workshop on Chronic Lymphocytic Leukemia (iwCLL), an international, non-profit association, committed to creating progress in the management and outcome of patients with chronic lymphocytic leukemia world-wide.
